Sort by
Refine Your Search
-
Category
-
Country
-
Program
-
Employer
-
Field
-
. This position is offered full time on a fixed term contract for 19 months and is funded by the National Institute of Health. Only applications received before 12 midday on Friday 3 May 2024 will be considered
-
project manager to join our dynamic team. The Center has a large portfolio of respiratory virus research studies in collaboration with the Centers for Disease Control and the National Institutes of Health
-
agencies including the National Institutes of Health. The Biostatistics Center is a leader in the statistical coordination of major medical research programs of national and international scope. Visit our
-
agencies including the National Institutes of Health. The Biostatistics Center is a leader in the statistical coordination of major medical research programs of national and international scope. Visit our
-
and regulations about clinical research to ensure compliance (i.e., Code of Federal Regulations). Interprets and applies requirements and standards set forth by the National Institutes of Health and the
-
proposal preparation and post-award management with an emphasis on National Institutes of Health (NIH) and other biomedical related funding agencies, including awards with multiple subawards, international
-
, King’s College London to fulfil annual reporting requirements to the National Institute for Health Research and the Department of Health. To ensure that appropriate acknowledgement is included in any peer
-
producing and processing grant applications and progress reports for various funding agencies and foundations such as National Institutes of Health, DoD, and Michael J. Fox Foundation. Responsible for
-
programs of the National Institutes of Health, National Eye Institute and other sources. Supervise the glaucoma clinic research team under the direction of principal investigators at the Hamilton Glaucoma
-
, and safety regulations, including the National Institute of Health (NIH) Guidelines for Research involving recombinant and synthetic DNA, Bloodborne Pathogens, federal Center’s for Disease Control and